GARRETT WHITTAKER: Open Payments
NPI 1174149462 · TORRINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 28 payments from 13 companies in 2025. Trend: 2023 $722 · 2024 $1,461 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $280 |
| AstraZeneca Pharmaceuticals LP | 4 | $267 |
| Phathom Pharmaceuticals, Inc. | 2 | $142 |
| Lilly USA, LLC | 4 | $110 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
Products named: BREZTRI, VRAYLAR, VOQUEZNA, MOUNJARO, QULIPTA, JARDIANCE, SHINGRIX, Veozah.
Industry payments across CT — which companies pay providers there.
